The Vanguard Group 13D and 13G filings for Turning Point Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-10 08:42 am Purchase |
2021-12-31 | 13G | Turning Point Therapeutics, Inc. TPTX |
The Vanguard Group | 3,877,339 7.840% |
436,879 (+12.70%) |
Filing |
| 2021-02-10 11:57 am Purchase |
2020-12-31 | 13G | Turning Point Therapeutics, Inc. TPTX |
The Vanguard Group | 3,440,460 7.140% |
1,475,226 (+75.07%) |
Filing |